2016
DOI: 10.1016/j.bmcl.2016.05.072
|View full text |Cite
|
Sign up to set email alerts
|

An alternative route to the arylvinyltriazole nucleosides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
3
0
1

Year Published

2019
2019
2021
2021

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 10 publications
1
3
0
1
Order By: Relevance
“…Neither of them displayed anti‐influenza A activity (H5 N1). These results confirm that the antiviral activity was influenced by the rigid bond between the triazole ring and aryl moiety, however, the steric molecular parameters contributed more significantly to activity than multiple bonds conjugation …”
Section: Introductionsupporting
confidence: 69%
See 3 more Smart Citations
“…Neither of them displayed anti‐influenza A activity (H5 N1). These results confirm that the antiviral activity was influenced by the rigid bond between the triazole ring and aryl moiety, however, the steric molecular parameters contributed more significantly to activity than multiple bonds conjugation …”
Section: Introductionsupporting
confidence: 69%
“…These results confirm that the antiviral activity was influenced by the rigid bond between the triazole ring and aryl moiety, however, the steric molecular parameters contributed more significantly to activity than multiple bonds conjugation. [60] On the same line, Chudinov et al prepared ribavirin analogs, 5-alkyl-substituted 1-β-D-ribofuranosyl-1,2,4-triazole-3carboxamides (41) ( Figure 12) and their antiviral activity was estimated in vitro on the reproduction of hepatitis C, herpes simplex, and influenza A viruses in cell cultures. Ribavirin (RBV) has been used as a positive control.…”
Section: Ribavirinmentioning
confidence: 99%
See 2 more Smart Citations
“…Нуклеозидные аналоги с простыми алкильными заместителями в положении 5 триазольного цикла практически неактивны против вируса гепатита С на клеточных моделях in vitro [105], а содержащие двойную связь аналоги соединения 26 (рис. 11) активны при транс-конфигурации (EC 50 = 9 мкМ, СС 50 > 30 мкМ) и неактивны в случае цис-конфигурации [109]. Рис.…”
Section: аналоги рибавирина замещенные по 5-му положению гетероциклаunclassified